July 2002

This sample business plan has been made available to users of Business Plan Pro®, business
planning software published by Palo Alto Software. Names, locations and numbers may have
been changed, and substantial portions of text may have been omitted from the original plan
to preserve confidentiality and proprietary information.

You are welcome to use this plan as a starting point to create your own, but you do not have
permission to reproduce, publish, distribute or even copy this plan as it exists here.

Requests for reprints, academic use, and other dissemination of this sample plan should be
emailed to the marketing department of Palo Alto Software at marketing@paloalto.com. For
product information visit our Website: www.paloalto.com or call: 1-800-229-7526.

Copyright Palo Alto Software, Inc., 1995-2002

 Confidentiality Agreement

The undersigned reader acknowledges that the information provided by in this business plan
is confidential; therefore, reader agrees not to disclose it without the express written permission of
.

It is acknowledged by reader that information to be furnished in this business plan is in all respects
confidential in nature, other than information which is in the public domain through other means and that
any disclosure or use of same by reader, may cause serious harm or damage to .

Upon request, this document is to be immediately returned to .

___________________
Signature

___________________
Name (typed or printed)

___________________
Date

This is a business plan. It does not imply an offering of securities.

 Table of Contents

1.0 Executive Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

1.1 Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.2 Mission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.3 Keys to Success . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

2.0 Company Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

2.1 Company Ownership . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
2.2 Company Locations and Facilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
2.3 Start-up Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

3.0 Products and Services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5

3.1 Product and Service Description . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
3.2 Competitive Comparison . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
3.3 Sales Literature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
3.4 Fulfillment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
3.5 Technology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
3.6 Future Products and Services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

4.0 Market Analysis Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

4.1 Market Segmentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
4.2 Target Market Segment Strategy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
4.2.1 Market Needs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
4.2.2 Market Trends . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
4.2.3 Market Growth . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
4.2.4 Market Concept Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
4.3 Industry Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
4.3.1 Business Participants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
4.3.2 Distribution Patterns . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
4.3.3 Competition and Buying Patterns . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
4.3.4 Main Competitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12

5.0 Strategy and Implementation Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12

5.1 Value Proposition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
5.2 Competitive Edge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
5.3 Positioning Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
5.4 Marketing Strategy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
5.4.1 Pricing Strategy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
5.4.2 Promotion Strategy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
5.4.3 Distribution Strategy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
5.4.4 Marketing Programs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
5.5 Sales Strategy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
5.5.1 Sales Forecast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
5.5.2 Sales Programs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
5.6 Strategic Alliances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16

6.0 Web Plan Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

6.1 Website Marketing Strategy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
6.2 Development Requirements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

7.0 Management Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

7.1 Organizational Structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
7.2 Management Team . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
7.3 Management Team Gaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
7.4 Personnel Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19

8.0 Financial Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20

 Table of Contents
8.1 Important Assumptions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
8.2 Break-even Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
8.3 Projected Profit and Loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
8.4 Projected Cash Flow . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
8.5 Projected Balance Sheet . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
8.6 Business Ratios . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
8.7 Exit Strategy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
 Sunapto

1.0 Executive Summary

Sunapto will manufacture and market an automated pill dispensing unit, the MedCabinet and
a companion monitoring service to fill the medication compliance problem in the United
States. The elderly often have multiple disease states and/or chronic conditions and consume
an average of four to five prescription drugs and two over-the-counter drugs per day. Nearly
67% of all elderly patients fail to follow important dosage instructions for their medications.
The risk of hospitalization due to adverse medication outcomes in elderly patients is almost 6
times greater than that for the general population.

Sunapto's mission is to provide people the opportunity to live better and healthier lives
though the use of technology. They will provide medical systems for the home that will use
patentable technology to ensure safety, ease of use and a continuous partnership with
healthcare providers. Their target market is the 65 and over age group. Thirty-five million
Americans are in this group and the group is growing at 1% per year. They intend to grow
the business and to establish their brand as a product leader and innovator in home
healthcare devices.

Sunapto's marketing strategy will follow from industry/trade and physician/pharmacist

awareness campaigns to specific executions directed at specific customer segments.
Sunapto's initial sales strategy is to sell the MedCabinet directly to consumers. The
MedCabinet is projected to sell for $700 and will provide medication users with the right pill
at the right time.

Sunapto faces competition in the medication compliance market from reminder devices,
automated medication dispensers and compliance services. The closest competitor to be
considered is a similar product in the automated medication dispenser and compliance
service market. Its weaknesses are its cost, limited dosing events and its weak marketing
and distribution channels. This makes it vulnerable to a new, improved entry.

Sunapto is in the pre-start-up stage. Sunapto will be formed as a start-up LLC in MidWest,
USA. The management team has experience in growth-oriented technology, business unit
development, finance, and team leadership and development. Having witnessed the problems
of medication compliance in their families, the management team is committed to being part
of the solution that addresses the compliance issue that plagues the elderly. Sunapto is
looking to add sales, marketing and medical device product development experience to its
management team.

The MedCabinet is in the concept development stage. Sunapto anticipates having a working
prototype five months after plan initiation and for sales to begin 12 months after plan
initiation. Initial sales projections are 11,077 units during Year 2 and 13,419 units during
Year 3.

Sunapto needs $1.18 million to bring the MedCabinet to market. They anticipate two rounds
of financing in the amounts of $470,000 and $710,000 respectively. The founders have
pledged $50,000 for Round 1. Sunapto is seeking the additional $420,000 from outside
investors before launching the company. These funds will be used for management team
gaps, prototype development and initial product marketing expenses. They anticipate Round
1 outside investors to realize a 60% return per annum over three years. Round 2 funding will
be needed during the seventh month of operations. Round 2 funds will be used for
management team gaps, prototype to product development, product marketing and for their
contract manufacturing production expenses. Sunapto anticipates Round 2 outside investors
to realize a 45% return per annum over three years.

Page 1
 Sunapto

1.1 Objectives

1. Increase sales to more than 24,000 MedCabinet units by Year 3.

2. Seven percent of units subscribed to monitoring and notification service by Year 3.

Highlights

$10,000,000

$8,000,000

$6,000,000
Sales
$4,000,000 Gross Margin
Net Profit
$2,000,000

$0

($2,000,000)
2003 2004 2005

1.2 Mission

Sunapto is a home healthcare technology company dedicated to enhancing peoples' lives by

bringing healthcare home. Sunapto provides home medical systems. These systems use
technology to ensure safety, ease of use, an independent lifestyle and a continuous
partnership with healthcare providers. Sunapto intends to seek a fair, yet aggressive profit,
which will allow the company to be financially healthy for the long term as well as provide
compensation to both owners and investors for their money and risk. They intend to grow the
business and to establish their brand as a product leader and innovator in home healthcare
devices. They intend to finance continued growth through a combination of equity investment
and internally generated cash flow. Sunapto will continue to develop new product extensions
once their marketing platform is established. Sunapto will maintain a strong and cohesive
work environment with a shared ethos and a passion to grow with the intensity that only
comes from belief.

Page 2
 Sunapto

1.3 Keys to Success

The keys to success for Sunapto are:

• Product Quality: A safe, reliable, easy to use product consisting of a well engineered
design, quality workmanship, easy to follow programming, accurate dispensing and
uncomplicated use.
• Marketing: Once a quality product is available, the success of Sunapto rests in the
marketing venue. The MedCabinet is a new product and consumers must be educated
to gain market penetration in a market comprised of people that often have a harder
time accepting new technology.
• Partnerships: Sunapto is a management/marketing/technology company, not a
manufacturing company. They will rely on partners to produce and deliver the
product. The establishment and maintenance of partnerships will be crucial.
• Philosophy: Sunapto is in business to earn a higher than normal return for its business
partners. In order to achieve this they will take a balanced approach in guiding the
company. Sunapto will not be driven blindly from the financial perspective, but will be
guided by four perspectives: Financial, Customer, Internal Process, and Learning &
Growth.

2.0 Company Summary

Sunapto will be a start-up Limited Liability Company (LLC) located in MidWest, USA. Sunapto
will manufacture and market the MedCabinet automatic pill dispenser, targeting the 65 and
over market segments. Initial market research has been completed and this business plan
will serve as the framework for bringing their product to market.

Sunapto is in the development stage and its proposed operations are subject to all the risks
inherent in the establishment of a new business enterprise, including the absence of an
operating history. The likelihood of Sunapto's success must be considered in light of the
problems, expenses, difficulties, complications and delays frequently encountered in
connection with the formation of a new business, and the competitive and regulatory
environment in which Sunapto will operate. Although forecast revenues and expenses are set
forth in this Plan, the actual amounts may vary substantially from those projected and no
assurance can be made that the results forecasted in this Plan will be achieved.

2.1 Company Ownership

It is anticipated that Sunapto will be structured as an LLC in MidWest, USA. Ownership will be
distributed amongst the founding partners. The founders intend to sell limited ownership to
outside private investors in external financing rounds.

Page 3
 Sunapto

2.2 Company Locations and Facilities

Sunapto is presently operated out of the home of the founder. Relocation to office space in
the greater MidWest, USA area is anticipated at the realization of this business plan. Initially,
the office space will be small to serve management of marketing functions, sales/ordering
processing and technical development. As Sunapto adds employees, they will take on
additional office space. Sunapto expects that space will be available in the future location.

Sunapto will conduct a search for a contract manufacturer for the MedCabinet. The contract
manufacturer will initially handle distribution. Orders will be drop shipped from the plant. This
eliminates the need to invest in distribution space at the outset.

2.3 Start-up Summary

Sunapto's start-up costs are expected to be minimal. They will be mostly stationery, legal
costs, and expenses associated with opening their first office. The start-up costs are to be
financed by direct owner investment. The assumptions are shown in the Start-up Table.

Start-up

$500,000
$450,000
$400,000
$350,000
$300,000
$250,000
$200,000
$150,000
$100,000
$50,000
$0
Expenses Assets Investment Loans

Page 4
 Sunapto

Table: Start-up

Start-up

Requirements

Start-up Expenses
Legal $2,000
Stationery etc. $500
Brochures $0
Consultants $0
Insurance $0
Rent $0
Research and Development $0
Expensed Equipment $0
Other $213
Total Start-up Expenses $2,713

Start-up Assets Needed

Cash Balance on Starting Date $470,000
Start-up Inventory $0
Other Current Assets $0
Total Current Assets $470,000

Long-term Assets $0
Total Assets $470,000
Total Requirements $472,713

Funding

Investment
John P. Brush $2,713
Founders $50,000
Round 1 Investors $420,000
Other $0
Total Investment $472,713

Current Liabilities
Accounts Payable $0
Current Borrowing $0
Other Current Liabilities $0
Current Liabilities $0

Long-term Liabilities $0
Total Liabilities $0

Loss at Start-up ($2,713)

Total Capital $470,000
Total Capital and Liabilities $470,000

3.0 Products and Services

Sunapto will initially develop and market one product and two companion services to enhance
the product.

1. MedCabinet, an automatic pill dispensing system. Its purpose is to facilitate

medication compliance/adherence and alleviate other common problems with
medication usage in the home, such as double dosing, losing pills and forgetting to
take pills. The MedCabinet will dispense the correct medication at the right time, and
will notify the user.
2. MedCabinet Monitoring Service provides secure website access to details about the
MedCabinet's dispensing activities.
3. MedCabinet Notification Service provides caregiver notification of events that may
disrupt the MedCabinet's dispensing activity or the user's medication compliance.

Page 5
 Sunapto

The technology used in the MedCabinet will contain items subject to patent protection.

3.1 Product and Service Description

A detailed and technical description of Sunapto's initial product and service line follows:

MedCabinet

The MedCabinet is an automatic pill dispensing system. The MedCabinet will dispense the
correct medication at the right time, and will notify the user of the medication's availability.
The MedCabinet provides protection against both serious and minor complications caused by
drug-related problems, especially in the elderly. The MedCabinet is a single user product and
is not intended to dispense medications to multiple users.

The MedCabinet has some specific safety features. The medications in the MedCabinet are
secured under lock and key. In the case of a caregiver, this protects the medications from
tampering by the person under care. In all instances, this protects the medications from
unauthorized access from others. The MedCabinet has a battery backup system to ensure
proper dispensing during a power outage.

The U.S. Food and Drug Administration (FDA)—Center for Devices and Radiological Health
(CDRH) monitors and controls medical devices. It is expected that the FDA will classify the
MedCabinet as a class I device. The FDA requires a manufacturer to register its class I device
but it does not require a premarket notification application or a clearance from the FDA
before marketing the device. As required by the FDA, the MedCabinet will be registered 30
days before manufacturing starts.

MedCabinet Monitor Service

The MedCabinet monitor service allows third parties to monitor the product's dispensing
activity. The monitoring activity is accessible by secure Web access.

MedCabinet Notification Service

The MedCabinet notification service allows third parties to be notified if a significant event
occurs in the product's dispensing activity. The notification service supports notifications by e-
mail, telephone, fax or pager. This service can be configured to contact the user in addition to
third parties.

3.2 Competitive Comparison

There are two options for organizing daily medications: the traditional weekly plastic pillbox
and an electronic version of the weekly pillbox. Both options rely on someone manually
separating the pills into the proper location and do not account for multiple medications that
are consumed at different intervals.

If someone is having trouble remembering to take their medications, a number of compliance

aids are available; ranging from simple pillboxes to services that will call to remind them to
take their pills.

• Daily or weekly pillboxes permit distribution of medications into individual

compartments based on the time of day the pills are to be taken. These can be
Page 6
 Sunapto
obtained from a pharmacist—sometimes free.
• Various electronic devices are available, including stands and caps that fit on the
bottle and clocks or watches that can be set to alert a user when it is time to take
their medicine.
• Automated dispensers will meter out pills and alert a user to take them.
• Computer programs and pagers are available to remind a user of medication times.
• Some pharmacies and home health agencies offer telephone reminder services.

The cost varies widely—from zero for free pillboxes to several hundred dollars for automated
dispensers and reminder services.

The closest product to the MedCabinet is the MED-Pharmacy II, or MP.2, developed by Home
Medical Services LLC.

3.3 Sales Literature

Sales literature for Sunapto and the MedCabinet remains to be developed.

3.4 Fulfillment

Sunapto is a technology company that develops product concepts, and supplies the
intelligence to these products in the form of software development. The establishment and
maintenance of a partnership to manufacture their products will be crucial. There are multiple
contract manufacturers in the marketplace. Sunapto will look to form a partnership with one
of these manufacturers to develop and produce the MedCabinet. Some of the essential
attributes that the partner Sunapto selects will have are listed below.

• Experience in the medical device field.

• Experience dealing with the FDA.
• Product development capabilities from product design/engineering to design for
manufacturability.
• Manufacturing.
• Order Fulfillment.
• Distribution.
• Depot and Repair.

3.5 Technology

Technology affects Sunapto, its manufacturing partner and the MedCabinet in a variety of
ways. As mentioned in the Fulfillment section, the contract manufacturer plays a crucial role
in Sunapto's success. A part of the evaluation of their contract manufacturer will be how the
manufacturer monitors and implements changes in manufacturing technology.

The MedCabinet will use both hardware and software technology to perform its function. The
technology chosen in these areas will be carefully selected to match a determined price and
performance point. The technology in the MedCabinet will be updated as needed to keep a
competitive price and performance point, but it is not anticipated to change as rapidly as
today's technology market.

The companion monitoring and notification service for the MedCabinet relies on Internet and

Page 7
 Sunapto
database technologies. As changes occur in these technologies, Sunapto will incorporate
these changes to benefit their customers.

The MedCabinet will contain patentable items that will require proper filings by a registered
patent attorney once created. Utility patents currently provide owners of the patent a 20-year
window from the time of filing to exclude others from using the technology.

3.6 Future Products and Services

Plans for future development by Sunapto include additional capabilities and enhancements to
the MedCabinet product line. It is the objective of Sunapto to both innovate and market its
products. Once an industry reputation has been achieved and marketing channels opened,
expansion into other healthcare and medical device areas becomes potentially rewarding.

4.0 Market Analysis Summary

Sunapto intends to target the 65 and over age group. Growth in this age category is expected
to be high over the next several years, as baby boomers approach and exceed age 65. U.S.
Census Bureau population projections estimate a 13.3% overall growth from 2001-2010 in
the 65 and over age group.

Medication compliance in home settings to insure proper drug administration is a major

unsatisfied need. As medication usage and life expectancy increase, and the shift towards
more in-home healthcare proliferates, this need will only be accentuated. The MedCabinet will
surpass the challenges imposed by this unsatisfied need and serve as a major asset to the
target market.

4.1 Market Segmentation

The potential customers of Sunapto are both domestic and foreign. This plan focuses on
Sunapto's potential domestic customers. Once established, the expansion into foreign
customers becomes potentially rewarding.

Individuals 65 and over residing in the U.S. that are using medications in an independent
living situation are the main customer group for the MedCabinet. About two-thirds of the 65
and over age group use prescription and over-the-counter (OTC) medications, and account
for about one-third of all prescription drug use. At any time, an average elderly person uses
four to five prescription drugs and two OTC drugs and fills 12 to 17 prescriptions a year.

Secondary customer groups for the MedCabinet are those under the age of 65 that need
assistance in medication compliance. This group includes individuals ranging from those
taking multiple medications to those needing help remembering when to take their
medication. Some of these individuals would include patients recovering from brain surgery,
patients taking a drug cocktail to combat HIV/AIDS, or Parkinson's Disease.

The following chart illustrates projected U.S. populations for various age segments; the
numbers in the table are in thousands. Many are potential buyers of the MedCabinet, but
Sunapto will initially concentrate on the 65 and over age group.

Page 8
 Sunapto

Table: Market Analysis

Market Analysis
Potential Customers Growth 2002 2003 2004 2005 2006 CAGR
65 years and over 1% 35,303 35,676 36,052 36,432 36,816 1.05%
55 to 64 years 4% 26,113 27,229 28,393 29,607 30,872 4.27%
18 to 54 years 0% 147,955 148,625 149,298 149,975 150,655 0.45%
Under 18 years 0% 70,935 71,153 71,371 71,590 71,810 0.31%
Other 0% 0 0 0 0 0 0.00%
Total 0.87% 280,306 282,683 285,114 287,604 290,153 0.87%

Market Analysis (Pie)

65 years and over

55 to 64 years
18 to 54 years
Under 18 years

4.2 Target Market Segment Strategy

Sunapto's choice of target markets is strategic. The 65 and over market have difficulty with
memory and in dealing with complicated dosage instructions for multiple medications. They
have a large unsatisfied medical compliance need. This is an expanding age group. The U.S.
Census Bureau estimates the 65 and over segment of the population will grow 3.7% from
2001-2005 and 9.2% from 2005-2010.

4.2.1 Market Needs

The elderly often have multiple disease states and/or chronic conditions. They consume over
one-third of the prescription medications in the United States. The average individual in
Sunapto's target market consumes four to five prescription drugs and two OTC drugs per
day. The risk of hospitalization due to adverse medication outcomes in elderly patients is
estimated at 17%, almost six times greater than that for the general population. Cognitive
impairment may play a major role in drug-related problems in the elderly, making it difficult
or impossible to correctly follow directions of appropriately prescribed medications. Other
factors include the lack of primary care provider help with medication management; financial
considerations that affect the purchase and regular use of medications; and decline in vision
that impairs the ability to correctly read directions. Nearly 67% of all patients fail to follow
important dosage instructions for their medications. Thirty-three percent of patients take all

Page 9
 Sunapto
their medicine, 33% take some and 33% do not take their medication at all. Some of the
negative outcomes resulting from drug-related problems are:

• Additional healthcare encounter.

• Additional medication.
• Emergency department or Urgent Care visits.
• Allied health professional visit (e.g. dietitian, physical therapist).
• Additional laboratory or radiology procedure.
• No treatment.
• Death.

The main customer need is medication compliance. In order for compliance to occur,
medication needs to be more easily organized and administered. The MedCabinet will address
this need.

4.2.2 Market Trends

The population in the United States is generally becoming older and is projected to continue
to do so. The reason for this is three fold. First, improvements in medication (both numbers
and types) and general healthcare has extended the average life-span of Americans to 79.5
years for women and 74.1 years for men according to a 2001 report by the National Center
for Health Statistics. The United State's average life span has increased by approximately
eight years over the past half-century, and it is expected to continue to increase in the future
(at a lower rate). Second, people have taken more self-interest in their health, and thus
found ways to prolong and enhance their lives. Finally, the baby boomer generation, the
largest single group in the U.S., is approaching 65 years of age.

4.2.3 Market Growth

There is little doubt that the population in the United States is aging. The U.S. Census Bureau
estimates that the mean age of the population will increase from 36 to 36.7 years during the
period of 2001-2005. This increase can be partially attributed to their estimates that the 65
and over segment of the population will grow approximately 1% each year from 2001-2005.
This amounts to approximately 350,000 individuals per year entering this age group, all
potential MedCabinet users.

Although the population is aging, more of the population is leading independent lives. Merck
& Co., Inc. reports in their Manual of Geriatrics that the percentage of elderly persons
residing in nursing homes has decreased to 5.2%

Page 10
 Sunapto

4.2.4 Market Concept Test

Sunapto's preliminary concept test showed a market penetration potential of 10%. While they
realize that this cannot be translated into actual market share, it does provide solid evidence
that their product would be viewed favorably. Sunapto estimates an initial market penetration
of 2%. This market penetration rate was estimated using the following formula.
1 2 3
Market Penetration = Market Share x Awareness x ACV
1
Market Share is determined using the top two box method. It is the
percentage of people who indicated in a product concept test that they
"definitely would buy" or "probably would buy" the product under concept
testing. In Sunapto's case, this number was 10%.
2
Awareness is the percentage of the target market that is aware of your
product. This number is a measure of the effectiveness of your advertising and
product recall by a consumer. Sunapto used a conservative 45%.
3
ACV (All Commodity Volume) is a measure of distribution reach. 70% ACV,
for example, means that a product is distributed in stores which represent
70% of sales volume of all products in the same category in that area. Sunapto
used a conservative 45%.

4.3 Industry Analysis

The medication compliance industry is extremely fragmented. The market consists of small
companies selling both electronic and traditional pill dispensers and organizers. There are no
major medical device companies making or distributing devices similar to the MedCabinet.
The consumer is generally unaware of available options, especially electronic products. These
consumers rely on expert advice from their physicians and pharmacists when making a
purchasing decision.

4.3.1 Business Participants

Currently, there are no major medical device companies making or distributing devices
similar to the MedCabinet. The market is very fragmented and is made up of smaller
companies selling both electronic and traditional (non-electronic) pill dispensers and
organizers. Many of the companies compete in the electronic compliance/reminder device
arena; few compete in the automated medication dispensers and compliance reminder
service arena.

Page 11
 Sunapto

4.3.2 Distribution Patterns

The majority of electronic devices in this industry are sold over the Internet with a few also
being listed in medical order guides. Non-electronic devices are sold in major retail outlets,
pharmacies, and through mail order. In general, distribution patterns in the healthcare
industry are such that the large buying and influencing groups dictate what products are used
throughout their sphere of influence. Thus, Sunapto's products could be mandated or forced
out for thousands of patients due to their health plan or hospital group. Other buying and
influencing groups recommend several alternatives that require physician and pharmacist
education and intervention, similar to pharmaceuticals.

4.3.3 Competition and Buying Patterns

In the home medical device market, buyers rely on expert advice when making a purchasing
decision. These experts are their primary care physicians, their pharmacist and their
healthcare insurance provider. Buyers are concerned about cost outlays and whether their
medical insurance carrier will bear any of the cost of products purchased.

Consumer awareness of automated pill dispensers is very low. Sixty-seven percent of the
respondents in Sunapto's market research indicated that the MedCabinet was unique.
Consumer awareness of the plastic pill holders (the seven compartment ones marked Sunday
through Saturday) is high. These holders are sold through a variety of means including mass
retail outlets like Wal-Mart.

4.3.4 Main Competitors

Sunapto faces competition on three main fronts in the medication compliance market. These
fronts are reminder devices, automated medication dispensers and compliance services. The
most important competitor to be considered is Home Medical Services LLC. Its strength is
that it has a similar product in the automated medication dispenser and compliance service
market. Its weaknesses are its cost, limited dosage days, and its weak marketing and
distribution channels. This makes it vulnerable to a new, improved entry.

5.0 Strategy and Implementation Summary

Sunapto will pursue specific, definable, market segments with a multi-tiered, multi-channel
approach. Marketing will follow from broad awareness campaigns to specific target customer
campaigns. Sunapto will sell directly to customers directed to them from their marketing
campaigns.

Page 12
 Sunapto

5.1 Value Proposition

Sunapto's value proposition is quite different from others. The MedCabinet is the only product
that will allow for prescription dosage and timing to avoid common compliance problems
prevalent in the primary target market. The companion services for the MedCabinet offer
third parties (e.g. healthcare providers, caregivers and/or family members) secure access to
vital information to help ensure proper medication compliance.

5.2 Competitive Edge

Sunapto has a competitive edge in three areas: technology, marketing/distribution and their
management team and advisory boards.

Technology: The MedCabinet will employ technology to enhance as much of the medication
process as possible. This will reduce the amount of human error in using the product. The
more user-friendly the product is, the more likely the user will maintain the proper
medication practices and thus avoid the need to see the doctor due to drug non-compliance.

Marketing and distribution: Sunapto believes that it is essential for the target market to be
exposed to the product via live demonstrations, doctor office visits or a friend in order to
remove the possible apprehension of technology. In order to get this desired exposure; they
need to get a large number of MedCabinets out in the market quickly, which means that the
pricing needs to be reasonable. Once the product has become established, Sunapto would
look to find a retail sales partner that would create even greater exposure and distribution of
their product.

Management team/Advisory boards: Sunapto's management team and advisory boards bring
a variety of skills and experiences to the table. Their Physician, Pharmacist and Home Nursing
Advisory Board consisting of individuals experienced in the areas of healthcare, medical
devices and elder care will help guide Sunapto to meet the growing and diverse needs of the
home healthcare marketplace. Sunapto's Business Advisory Board will support, mentor and
enhance Sunapto's management team. Please refer to section 7.2 for the management team
listing.

5.3 Positioning Statements

For the person, or caregiver of a person, who is on a medication plan, the MedCabinet helps
avoid many of the pitfalls associated with medication non-compliance by providing the right
medication at the right time.

Page 13
 Sunapto

5.4 Marketing Strategy

Marketing will follow from industry/trade, and physician/pharmacist awareness campaigns to

specific executions directed at specific customer segments. Once the product has gained
acceptance by individuals and care providers, Sunapto will initiate the second phase of their
marketing strategy. Stage 2 will comprise three steps.

1. Cast wider sales net over healthcare providers.

2. Begin advertising campaign focusing on the elderly.
3. Facilitate and rely on a strong word-of-mouth campaign.

5.4.1 Pricing Strategy

Sunapto plans to price the MedCabinet at $700 in order to encourage both medically insured
as well as non-insured consumers to buy the product. It is their intention to lobby insurance
providers to help cover some or all of the cost of the MedCabinet.

The MedCabinet Monitor and Notification Service is priced at $19.95 per month.

5.4.2 Promotion Strategy

Public relations and industry media will help in Sunapto's over-all industry awareness plans.
Feature articles and product reviews will help launch awareness. Direct mail to buying and
influencing groups and ads in trade and consumer target publications will help with buyer
impressions.

Sunapto will work closely with physicians and home nursing professionals to design its
product and services. The importance of working with physicians is well known. As an
outgrowth of their Physician, Pharmacist and Home Nursing Advisory Board, Sunapto will
actively recruit physicians, pharmacists and home nursing professionals with sponsored
events and seminars.

5.4.3 Distribution Strategy

MedCabinet production will be outsourced to a contract manufacturer. Once an order is

placed with Sunapto, their order-taking system will automatically notify the production
company regarding shipping details. Software using Internet technology will provide an
efficient mechanism for streamlining the ordering, production and delivery process.

Their product will initially be shipped directly from the contract manufacturer at the
customer's expense. The MedCabinet manufacturer will include receipts, instructions and
other Sunapto literature.

Once the MedCabinet requires distribution to a wider array of buyers, Sunapto will consider a
separate distribution center(s) to handle additional demand.

Page 14
 Sunapto

5.4.4 Marketing Programs

Specific marketing programs for Sunapto and the MedCabinet remain to be developed.

5.5 Sales Strategy

Sunapto's initial strategy is to sell the MedCabinet directly to consumers. Once sales have
reached a respectable level, Sunapto will begin discussions with retail sales outlets to stock
and sell their product(s).

5.5.1 Sales Forecast

No sales are anticipated throughout Year 1 of operations, as the MedCabinet is developed.

The first sales are expected to begin in Year 2. The annual sales forecast for Year 2 is 11,077
MedCabinet units with 7% of the sold units purchasing the companion services. For Year 3,
the expected sales forecast is 13,419 units, again with 7% of the sold units purchasing the
companion services. It is anticipated that at the end of Year 3, Sunapto will have 1,716
subscribers to the MedCabinet companion services. The estimates presented in this section
were derived using a conservative statistical methodology for estimated market penetration
for a medical product of this type. For additional details reference section 4.2.4 Market
Concept Test.

Sales by Year (Planned)

$10,000,000

$8,000,000

$6,000,000 MedCabinet PMA

MedCabinet Monitor & Notification Service
$4,000,000
MedCabinet M&N Service Renewal
$2,000,000

$0
2003 2004 2005

Page 15
 Sunapto

Table: Sales Forecast

Sales Forecast
Unit Sales 2003 2004 2005
MedCabinet PMA 0 11,077 13,419
MedCabinet Monitor & Notification Service 0 776 940
MedCabinet M&N Service Renewal 0 0 776
Other 0 0 0
Total Unit Sales 0 11,853 15,135

Unit Prices 2003 2004 2005

MedCabinet PMA $0.00 $700.00 $700.00
MedCabinet Monitor & Notification Service $0.00 $301.06 $301.06
MedCabinet M&N Service Renewal $0.00 $239.40 $239.40
Other $0.00 $0.00 $0.00

Sales
MedCabinet PMA $0 $7,753,900 $9,393,300
MedCabinet Monitor & Notification Service $0 $233,623 $282,997
MedCabinet M&N Service Renewal $0 $0 $185,774
Other $0 $0 $0
Total Sales $0 $7,987,523 $9,862,072

Direct Unit Costs 2003 2004 2005

MedCabinet PMA $0.00 $420.00 $420.00
MedCabinet Monitor & Notification Service $0.00 $30.14 $30.14
MedCabinet M&N Service Renewal $0.00 $24.00 $24.00
Other $0.00 $0.00 $0.00

Direct Cost of Sales 2003 2004 2005

MedCabinet PMA $0 $4,652,340 $5,635,980
MedCabinet Monitor & Notification Service $0 $23,386 $28,328
MedCabinet M&N Service Renewal $0 $0 $18,624
Other $0 $0 $0
Subtotal Direct Cost of Sales $0 $4,675,726 $5,682,932

5.5.2 Sales Programs

Direct sales will be by personal contact, direct mail, public relations and media directed at
key industry and customer segments. In addition, electronic marketing will be deployed
whenever it fits with the buying or influencing patterns of a key group. A website and
electronic commerce site will be utilized to cultivate direct sales to key industry groups and
end consumers.

5.6 Strategic Alliances

Sunapto will depend upon strategic alliances in the following areas.

• Contract sales organization to position and sell their product in the national
healthcare market.
• Contract design and manufacturer to develop and consistently deliver a quality
product.
• Website developer and host to provide continuous access to Sunapto's current and
potential customers.

Page 16
 Sunapto

6.0 Web Plan Summary

The Sunapto MedCabinet website will be the virtual business card and portfolio for the
company, as well as their online "home."

It will highlight the MedCabinet and provide access to the monitor and notification service.
The website is part of Sunapto's overall marketing mix. Its main purpose will be to provide
information and service to existing customers. It will have a commerce section to allow new
customers to purchase Sunapto's offered products and services.

The website needs to be simple yet classy, and well-designed at the same time, and is in
keeping with the latest trends in user interface design. A site that is too flashy, or tries to use
too much of the latest Shockwave or Flash technology can be overdone.

Sunapto plans to contract out the development and hosting of the initial MedCabinet website.

6.1 Website Marketing Strategy

The MedCabinet content/commerce site will focus on providing customer service, access to
the MedCabinet Monitor and Notification service, products and product information to the
healthcare community, caregivers and customer segments. The site will also provide
informational and educational content relating to medication compliance/adherence issues.

Sunapto's website will have a fast loading, extremely user-friendly user interface (UI). The UI
will be key to the Web strategy, as it needs to appeal to the audience and at the same time
be simple and clean.

6.2 Development Requirements

Sunapto plans to contract out the development and hosting of the initial MedCabinet website.
Sunapto will work closely with a selected website developer to develop a simple, classy, yet
Internet focused site that satisfies the needs of Sunapto's target groups.

7.0 Management Summary

Sunapto is owned and operated by its founders. It is a small company with a minimum
command hierarchy and a maximum of community spirit and cooperation. Despite the loose
style, Sunapto is organized by function, and the business is done with logic and order.
Management of the company is based upon the following foundation.

1. Build and Maintain a Cohesive Leadership Team.

2. Create Organizational Clarity.
3. Over-Communicate Organizational Clarity.
4. Reinforce Organizational Clarity Through Human Systems.

Several key people are actively being sought. These are summarized in the Management
Team Gaps section.

Page 17
 Sunapto

7.1 Organizational Structure

The general organization structure of Sunapto is displayed in the chart below.

Organizational Chart

President

Engineering Director Sales and Marketing Director Controller Customer Service Manager

Engineering Staff
Sales Representatives Business Manager Customer Service Reps

Administrative Staff

7.2 Management Team

John P. Brush, President: 41 years old, founded Sunapto in 2002 to focus on using technology to enhance
home healthcare. John spent sixteen years at SCS, Inc. before returning to school to obtain his MBA. John
was part of the management team that grew SCS from 4 to 55 employees with sales of $5 million. John
opened SCS's first remote office and grew it to 37% of corporate sales in four years. He earned his MBA
from the University of Notre Dame's Mendoza College of Business, and BS (Computer Science) from Rose-
Hulman Institute of Technology.

Resumes for the management team may be found in the appendices.

7.3 Management Team Gaps

Sunapto has a good team for covering the main points of the business plan.

At present, Sunapto is weakest in the area of marketing capabilities to position their company and product
in the medical marketplace. Sunapto also needs to find technical capabilities to manage the engineering
portion of product development.

Sunapto plans to build two advisory boards. One will be the Physician, Pharmacist and Home Nursing
Advisory Board consisting of individuals experienced in the areas of healthcare, medical devices and elder
care. The second will be an advisory board consisting of individuals with expertise in business development
and growth along with medical device product development. The advisor boards will be used to support and
supplement the management team.

Listed below are the key management positions that will need to be filled. Each position listed also contains
a brief job description and background requirement.

Sales and Marketing Director—Develops strategic sales and marketing objectives, establishes sales

Page 18
 Sunapto
territories and quotas, manages budgets and evaluates sales performance. Manages and develops
marketing programs and materials such as, advertising, event support and promotions. Requires a
bachelor's degree with at least 7-10 years of sales and marketing experience. Must be familiar with both
medical and Internet business models and technologies. Experience must include product/brand
management where the emphasis was on managing, developing, and implementing product-marketing
activities to maximize sales of an assigned product line.

Controller—Responsible for directing the accounting functions. These functions include establishing and
maintaining accounting principles, practices and procedures. Prepares financial reports and presents
findings and recommendations. Requires a bachelor's degree and at least 7 years of direct experience in
the field.

Engineering Manager—Plans and directs all aspects of engineering activities within the organization.
Ensures all engineering projects, initiatives and processes are in conformance with organization's
established policies and objectives. Requires a bachelor's degree in engineering and 8 to 10 years of
experience in various engineering fields.

7.4 Personnel Plan

The Personnel Plan reflects the need to bolster Sunapto's capabilities to match their positioning. Sunapto's
total employment should increase to 10 during Year 1 and to 16 by Year 3. Detailed monthly projections are
included in the appendices.
Table: Personnel

Personnel Plan
Production Personnel 2003 2004 2005
Engineering Manager $94,908 $97,755 $100,688
Software Engineer III $43,577 $67,332 $69,352
Software Engineer II $25,524 $52,583 $54,160
Database Administrator $28,656 $58,902 $60,669
Other $0 $0 $0
Subtotal $192,665 $276,572 $284,869

Sales and Marketing Personnel

Sales and Marketing Director $85,920 $88,498 $91,153
Other $0 $0 $0
Subtotal $85,920 $88,498 $91,153

General and Administrative Personnel

President $75,000 $102,500 $130,000
Business Office Manager $26,600 $46,968 $48,377
Administrative Assistant $16,044 $28,324 $29,174
Controller $95,292 $98,151 $101,095
Other $0 $0 $0
Subtotal $212,936 $275,943 $308,646

Other Personnel
Customer Service / Call Center Manager $22,770 $46,901 $48,308
Customer Service Rep $0 $29,652 $30,542
Customer Service Rep $0 $29,652 $30,542
Customer Service Rep $0 $0 $30,542
Customer Service Rep $0 $0 $30,542
Customer Service Rep $0 $0 $30,542
Webmaster $0 $46,466 $47,860
Other $0 $0 $0
Subtotal $22,770 $152,671 $248,876

Total People 10 13 16
Total Payroll $514,291 $793,684 $933,544

Page 19
 Sunapto

8.0 Financial Plan

Sunapto desires to finance growth through a combination of equity investment and internally generated
cash flow. Because of the cost of initial product development and marketing costs of establishing a market
presence, the business will be financed primarily by investment in the early stages and is expected to burn
cash.

The company intends to raise an amount of approximately $420,000 of seed capital before launch and an
additional $710,000 after prototype development.

8.1 Important Assumptions

The financial plan depends on important assumptions, most of which are shown in the following table. The
important underlying assumptions are:

• A recovering economy.
• No changes in technology to make products immediately obsolete.
• Access to equity capital and financing sufficient to maintain Sunapto's financial plan as shown in
the tables.

Table: General Assumptions

General Assumptions
2003 2004 2005
Plan Month 1 2 3
Current Interest Rate 10.00% 10.00% 10.00%
Long-term Interest Rate 10.00% 10.00% 10.00%
Tax Rate 35.00% 35.00% 35.00%
Sales on Credit % 10.00% 10.00% 10.00%
Other 0.00% 0.00% 0.00%
Calculated Totals
Payroll Expense $514,291 $793,684 $933,544
Sales on Credit $0 $798,752 $986,207
New Accounts Payable $1,148,436 $6,482,379 $7,853,356
Inventory Purchase $0 $4,675,726 $5,682,932

Page 20
 Sunapto

8.2 Break-even Analysis

Sunapto's break-even analysis assumes running costs of approximately $173,000 per month. This amount
is the average of Year 2 and Year 3 expenses, which includes their full payroll, rent, utilities, and an
estimation of other running costs.

Margins are harder to assume. Sunapto's overall average of $661/$384 is based on projected total sales in
Year 2 and Year 3.

The chart shows that Sunapto needs to sell about $413,000 or 624 MedCabinet units, per month to break-
even, according to these assumptions.

Table: Break-even Analysis

Break-even Analysis:
Monthly Units Break-even 624
Monthly Revenue Break-even $412,750

Assumptions:
Average Per-Unit Revenue $661.00
Average Per-Unit Variable Cost $384.00
Estimated Monthly Fixed Cost $172,968

Break-even Analysis

$150,000

$100,000

$50,000

$0

($50,000)

($100,000)

($150,000)

($200,000)
0 200 400 600 800 1000

Monthly break-even point

Break-even point = where line intersects with 0

Page 21
 Sunapto

8.3 Projected Profit and Loss

Barring any unforeseen circumstances, Sunapto is anticipated to break-even by Year 2 of operations.

Profits for the company in subsequent years will accelerate with the increase in anticipated sales volume,
yielding approximately $983,000 in net profit in Year 2 and $1.5 million in Year 3.

Table: Profit and Loss

Pro Forma Profit and Loss

2003 2004 2005
Sales $0 $7,987,523 $9,862,072
Direct Costs of Goods $0 $4,675,726 $5,682,932
Production Payroll $192,665 $276,572 $284,869
Research and Development $175,000 $180,250 $185,658
Other Production Expenses $0 $0 $0
------------ ------------ ------------
Cost of Goods Sold $367,665 $5,132,548 $6,153,459
Gross Margin ($367,665) $2,854,975 $3,708,613
Gross Margin % 0.00% 35.74% 37.60%
Operating Expenses:
Sales and Marketing Expenses:
Sales and Marketing Payroll $85,920 $88,498 $91,153
Contract Sales Organization $50,000 $273,000 $312,000
Advertising/Promotions $143,775 $177,517 $216,284
Travel $6,000 $7,800 $10,140
Sales Commissions $0 $116,309 $140,900
Legal $12,000 $12,360 $12,731
Miscellaneous $2,400 $2,472 $2,546
------------ ------------ ------------
Total Sales and Marketing Expenses $300,095 $677,955 $785,753
Sales and Marketing % 0.00% 8.49% 7.97%
General and Administrative Expenses:
General and Administrative Payroll $212,936 $275,943 $308,646
Sales and Marketing and Other Expenses $0 $0 $0
Depreciation $0 $0 $0
Leased Equipment $0 $0 $0
Utilities $36,000 $37,080 $38,192
Insurance $12,000 $12,360 $12,731
Office Equipment $30,000 $9,000 $9,000
Office Supplies $6,000 $6,180 $6,365
Rent $60,000 $61,800 $63,654
Payroll Taxes $154,287 $238,105 $280,063
Other General and Administrative Expenses $0 $0 $0
------------ ------------ ------------
Total General and Administrative Expenses $511,223 $640,468 $718,652
General and Administrative % 0.00% 8.02% 7.29%
Other Expenses:
Other Payroll $22,770 $152,671 $248,876
Contract/Consultants $0 $0 $0
------------ ------------ ------------
Total Other Expenses $22,770 $152,671 $248,876
Other % 0.00% 1.91% 2.52%
------------ ------------ ------------
Total Operating Expenses $834,089 $1,471,094 $1,753,281
Profit Before Interest and Taxes ($1,201,754) $1,383,881 $1,955,332
Interest Expense $0 $0 $0
Taxes Incurred $0 $484,358 $684,366
Net Profit ($1,124,364) $983,596 $1,629,417
Net Profit/Sales 0.00% 12.31% 16.52%
Include Negative Taxes FALSE TRUE TRUE

Page 22
 Sunapto

Profit Monthly

$0

($20,000)

($40,000)

($60,000)

($80,000)

($100,000)

($120,000)

($140,000)

($160,000)

($180,000)

($200,000)
Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun

Profit Yearly

$2,000,000

$1,500,000

$1,000,000

$500,000

$0

($500,000)

($1,000,000)

($1,500,000)
2003 2004 2005

Page 23
 Sunapto

Gross Margin Monthly

$0

($10,000)

($20,000)

($30,000)

($40,000)

($50,000)

($60,000)

($70,000)
Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun

Gross Margin Yearly

$4,000,000

$3,500,000

$3,000,000

$2,500,000

$2,000,000

$1,500,000

$1,000,000

$500,000

$0

($500,000)
2003 2004 2005

Page 24
 Sunapto

8.4 Projected Cash Flow

It should be noted that the company's cash flow will be steadily declining for the first year of operations.
This is expected due to large capital investments and no sales. Sunapto anticipates having negative net
cash flows throughout Year 1 as they incur expenses for prototype development during the first half and as
they get ready for production by their contract manufacturer during the second half. Two infusions of capital
totaling $1.18 million will get Sunapto through the cash flow drain as they build up for production and sales
to begin in Year 2. A monthly breakdown of Year 1 cash flow may be found in the appendix.

Cash

$700,000

$600,000

$500,000

$400,000

$300,000
Net Cash Flow
$200,000
Cash Balance
$100,000

$0

($100,000)

($200,000)
Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun

Page 25
 Sunapto

Table: Cash Flow

Pro Forma Cash Flow 2003 2004 2005

Cash Received
Cash from Operations:
Cash Sales $0 $7,188,771 $8,875,865
Cash from Receivables $0 $798,752 $986,207
Subtotal Cash from Operations $0 $7,987,523 $9,862,072

Additional Cash Received

Non Operating (Other) Income $38,695 $84,073 $179,225
Sales Tax, VAT, HST/GST Received $0 $0 $0
New Current Borrowing $0 $0 $0
New Other Liabilities (interest-free) $0 $0 $0
New Long-term Liabilities $0 $0 $0
Sales of Other Current Assets $0 $0 $0
Sales of Long-term Assets $0 $0 $0
New Investment Received $710,000 $0 $0
Subtotal Cash Received $748,695 $8,071,596 $10,041,297

Expenditures 2003 2004 2005

Expenditures from Operations:
Cash Spending $53,318 $605,621 $737,750
Payment of Accounts Payable $1,117,812 $6,165,153 $7,777,465
Subtotal Spent on Operations $1,171,130 $6,770,774 $8,515,215

Additional Cash Spent

Non Operating (Other) Expense ($38,695) $0 ($179,225)
Sales Tax, VAT, HST/GST Paid Out $0 $0 $0
Principal Repayment of Current Borrowing $0 $0 $0
Other Liabilities Principal Repayment $0 $0 $0
Long-term Liabilities Principal Repayment $0 $0 $0
Purchase Other Current Assets $0 $0 $0
Purchase Long-term Assets $0 $0 $0
Dividends $0 $0 $0
Subtotal Cash Spent $1,132,435 $6,770,774 $8,335,990

Net Cash Flow ($383,740) $1,300,822 $1,705,307

Cash Balance $86,260 $1,387,082 $3,092,390

Page 26
 Sunapto

8.5 Projected Balance Sheet

The table below presents the Balance Sheet for Sunapto.

Table: Balance Sheet

Pro Forma Balance Sheet

Assets
Current Assets 2003 2004 2005
Cash $86,260 $1,387,082 $3,092,390
Accounts Receivable $0 $0 $0
Inventory $0 $0 $0
Other Current Assets $0 $0 $0
Total Current Assets $86,260 $1,387,082 $3,092,390
Long-term Assets
Long-term Assets $0 $0 $0
Accumulated Depreciation $0 $0 $0
Total Long-term Assets $0 $0 $0
Total Assets $86,260 $1,387,082 $3,092,390

Liabilities and Capital

2003 2004 2005
Accounts Payable $30,624 $347,851 $423,741
Current Borrowing $0 $0 $0
Other Current Liabilities $0 $0 $0
Subtotal Current Liabilities $30,624 $347,851 $423,741

Long-term Liabilities $0 $0 $0
Total Liabilities $30,624 $347,851 $423,741

Paid-in Capital $1,182,713 $1,182,713 $1,182,713

Retained Earnings ($2,713) ($1,127,077) ($143,481)
Earnings ($1,124,364) $983,596 $1,629,417
Total Capital $55,636 $1,039,231 $2,668,648
Total Liabilities and Capital $86,260 $1,387,082 $3,092,390
Net Worth $55,636 $1,039,231 $2,668,648

8.6 Business Ratios

The table follows with Sunapto's main business ratios. The Industry figures come from the Standard
Industry Classification (SIC) Index Code 3845, Electromedical Equipment.

Page 27
 Sunapto

Table: Ratios

Ratio Analysis
2003 2004 2005 Industry Profile
Sales Growth 0.00% 0.00% 23.47% 2.30%

Percent of Total Assets

Accounts Receivable 0.00% 0.00% 0.00% 26.40%
Inventory 0.00% 0.00% 0.00% 13.10%
Other Current Assets 0.00% 0.00% 0.00% 47.70%
Total Current Assets 100.00% 100.00% 100.00% 87.20%
Long-term Assets 0.00% 0.00% 0.00% 12.80%
Total Assets 100.00% 100.00% 100.00% 100.00%

Current Liabilities 0.00% 0.00% 0.00% 38.10%

Long-term Liabilities 0.00% 0.00% 0.00% 18.70%
Total Liabilities 0.00% 0.00% 0.00% 56.80%
Net Worth 100.00% 100.00% 100.00% 43.20%

Percent of Sales
Sales 100.00% 100.00% 100.00% 100.00%
Gross Margin 0.00% 35.74% 37.60% 53.30%
Selling, General & Administrative Expenses 0.00% 23.43% 22.90% 34.50%
Advertising Expenses 0.00% 3.42% 3.16% 1.80%
Profit Before Interest and Taxes 0.00% 17.33% 19.83% 4.70%

Main Ratios
Current 2.82 3.99 7.30 1.97
Quick 2.82 3.99 7.30 1.34
Total Debt to Total Assets 35.50% 25.08% 13.70% 56.80%
Pre-tax Return on Net Worth -2160.04% 133.16% 73.27% 4.10%
Pre-tax Return on Assets -1393.18% 99.77% 63.23% 9.40%

Business Vitality Profile 2002 2003 2004 Industry

Sales per Employee $0 $614,425 $616,379 $0
Survival Rate 0.00%

Additional Ratios 2003 2004 2005

Net Profit Margin 0.00% 12.31% 16.52% n.a
Return on Equity -2020.94% 94.65% 61.06% n.a

Activity Ratios
Accounts Receivable Turnover 0.00 0.00 0.00 n.a
Collection Days 0 0 0 n.a
Inventory Turnover 0.00 0.00 0.00 n.a
Accounts Payable Turnover 37.50 18.64 18.53 n.a
Payment Days 11 128 215
Total Asset Turnover 0.00 5.76 3.19 n.a

Debt Ratios
Debt to Net Worth 0.55 0.33 0.16 n.a
Current Liab. to Liab. 1.00 1.00 1.00 n.a

Liquidity Ratios
Net Working Capital $55,636 $1,039,231 $2,668,648 n.a
Interest Coverage 0.00 0.00 0.00 n.a

Additional Ratios
Assets to Sales n.a. 0.17 0.31 n.a
Current Debt/Total Assets 36% 25% 14% n.a
Acid Test 2.82 3.99 7.30 n.a
Sales/Net Worth 0.00 7.69 3.70 n.a
Dividend Payout 0.00 0.00 0.00 n.a

Page 28
 Sunapto

8.7 Exit Strategy

Sunapto is in business to earn a higher than normal return for its business partners. They intend to seek a
fair, yet aggressive profit, which will allow the company to be financially healthy for the long term as well as
provide compensation to both owners and investors for their money and risk. Sunapto's founders intend to
be part of the ownership and management of Sunapto. Sunapto recognizes that all of its investors will
eventually want to reap the rewards of their investments. The following exit strategies are possible ways
that Sunapto may choose to reward its early round investors.

• An IPO.
• A sale to a strategic buyer.
• A leveraged recapitalization.
• A new round of financing.

Page 29
 Appendix

Appendix Table: Sales Forecast

Sales Forecast
Unit Sales Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun
MedCabinet PMA 0 0 0 0 0 0 0 0 0 0 0 0
MedCabinet Monitor & Notification Service 0 0 0 0 0 0 0 0 0 0 0 0
MedCabinet M&N Service Renewal 0 0 0 0 0 0 0 0 0 0 0 0
Other 0 0 0 0 0 0 0 0 0 0 0 0
Total Unit Sales 0 0 0 0 0 0 0 0 0 0 0 0

Unit Prices Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun
MedCabinet PMA $700.00 $700.00 $700.00 $700.00 $700.00 $700.00 $700.00 $700.00 $700.00 $700.00 $700.00 $700.00
MedCabinet Monitor & Notification Service $19.95 $19.95 $19.95 $19.95 $19.95 $19.95 $19.95 $19.95 $19.95 $19.95 $19.95 $19.95
MedCabinet M&N Service Renewal $19.95 $19.95 $19.95 $19.95 $19.95 $19.95 $19.95 $19.95 $19.95 $19.95 $19.95 $19.95
Other $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00

Sales
MedCabinet PMA $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
MedCabinet Monitor & Notification Service $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
MedCabinet M&N Service Renewal $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Other $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Total Sales $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0

Direct Unit Costs Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun
MedCabinet PMA $420.00 $420.00 $420.00 $420.00 $420.00 $420.00 $420.00 $420.00 $420.00 $420.00 $420.00 $420.00
MedCabinet Monitor & Notification Service $2.00 $2.00 $2.00 $2.00 $2.00 $2.00 $2.00 $2.00 $2.00 $2.00 $2.00 $2.00
MedCabinet M&N Service Renewal $2.00 $2.00 $2.00 $2.00 $2.00 $2.00 $2.00 $2.00 $2.00 $2.00 $2.00 $2.00
Other $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00

Direct Cost of Sales Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun
MedCabinet PMA $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
MedCabinet Monitor & Notification Service $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
MedCabinet M&N Service Renewal $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Other $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Subtotal Direct Cost of Sales $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0

Page 1
 Appendix

Appendix Table: Personnel

Personnel Plan
Production Personnel Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun
Engineering Manager $7,909 $7,909 $7,909 $7,909 $7,909 $7,909 $7,909 $7,909 $7,909 $7,909 $7,909 $7,909
Software Engineer III $0 $0 $0 $1 $5,447 $5,447 $5,447 $5,447 $5,447 $5,447 $5,447 $5,447
Software Engineer II $0 $0 $0 $0 $0 $0 $4,254 $4,254 $4,254 $4,254 $4,254 $4,254
Database Administrator $0 $0 $0 $0 $0 $0 $4,776 $4,776 $4,776 $4,776 $4,776 $4,776
Other $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Subtotal $7,909 $7,909 $7,909 $7,910 $13,356 $13,356 $22,386 $22,386 $22,386 $22,386 $22,386 $22,386

Sales and Marketing Personnel

Sales and Marketing Director $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160
Other $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Subtotal $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160

General and Administrative Personnel

President $6,250 $6,250 $6,250 $6,250 $6,250 $6,250 $6,250 $6,250 $6,250 $6,250 $6,250 $6,250
Business Office Manager $0 $0 $0 $0 $0 $3,800 $3,800 $3,800 $3,800 $3,800 $3,800 $3,800
Administrative Assistant $0 $0 $0 $0 $0 $2,292 $2,292 $2,292 $2,292 $2,292 $2,292 $2,292
Controller $7,941 $7,941 $7,941 $7,941 $7,941 $7,941 $7,941 $7,941 $7,941 $7,941 $7,941 $7,941
Other $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Subtotal $14,191 $14,191 $14,191 $14,191 $14,191 $20,283 $20,283 $20,283 $20,283 $20,283 $20,283 $20,283

Other Personnel
Customer Service / Call Center Manager $0 $0 $0 $0 $0 $0 $3,795 $3,795 $3,795 $3,795 $3,795 $3,795
Customer Service Rep $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Customer Service Rep $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Customer Service Rep $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Customer Service Rep $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Customer Service Rep $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Webmaster $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Other $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Subtotal $0 $0 $0 $0 $0 $0 $3,795 $3,795 $3,795 $3,795 $3,795 $3,795

Total People 4 4 4 5 5 7 10 10 10 10 10 10
Total Payroll $29,260 $29,260 $29,260 $29,261 $34,707 $40,799 $53,624 $53,624 $53,624 $53,624 $53,624 $53,624

Page 2
 Appendix

Appendix Table: General Assumptions

General Assumptions
Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun
Plan Month 1 2 3 4 5 6 7 8 9 10 11 12
Current Interest Rate 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00%
Long-term Interest Rate 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00%
Tax Rate 35.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00%
Sales on Credit % 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00%
Other 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Calculated Totals
Payroll Expense $29,260 $29,260 $29,260 $29,261 $34,707 $40,799 $53,624 $53,624 $53,624 $53,624 $53,624 $53,624
Sales on Credit $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
New Accounts Payable $97,393 $47,218 $47,218 $132,427 $54,299 $67,619 $180,299 $78,891 $78,891 $161,399 $101,391 $101,391
Inventory Purchase $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0

Page 3
 Appendix

Appendix Table: Profit and Loss

Pro Forma Profit and Loss

Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun
Sales $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Direct Costs of Goods $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Production Payroll $7,909 $7,909 $7,909 $7,910 $13,356 $13,356 $22,386 $22,386 $22,386 $22,386 $22,386 $22,386
Research and Development $43,750 $0 $0 $43,750 $0 $0 $43,750 $0 $0 $43,750 $0 $0
Other Production Expenses $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------
Cost of Goods Sold $51,659 $7,909 $7,909 $51,660 $13,356 $13,356 $66,136 $22,386 $22,386 $66,136 $22,386 $22,386
Gross Margin ($51,659) ($7,909) ($7,909) ($51,660) ($13,356) ($13,356) ($66,136) ($22,386) ($22,386) ($66,136) ($22,386) ($22,386)
Gross Margin % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses:
Sales and Marketing Expenses:
Sales and Marketing Payroll $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160 $7,160
Contract Sales Organization $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $25,000 $25,000
Advertising/Promotions $0 $0 $0 $47,925 $0 $0 $47,925 $0 $0 $47,925 $0 $0
Travel $500 $500 $500 $500 $500 $500 $500 $500 $500 $500 $500 $500
Sales Commissions $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Legal $0 $0 $0 $0 $0 $0 $12,000 $0 $0 $0 $0 $0
Miscellaneous $200 $200 $200 $200 $200 $200 $200 $200 $200 $200 $200 $200
------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------
Total Sales and Marketing Expenses $7,860 $7,860 $7,860 $55,785 $7,860 $7,860 $67,785 $7,860 $7,860 $55,785 $32,860 $32,860
Sales and Marketing % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
General and Administrative Expenses:
General and Administrative Payroll $14,191 $14,191 $14,191 $14,191 $14,191 $20,283 $20,283 $20,283 $20,283 $20,283 $20,283 $20,283
Sales and Marketing and Other Expenses $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Depreciation $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Leased Equipment $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Utilities $3,000 $3,000 $3,000 $3,000 $3,000 $3,000 $3,000 $3,000 $3,000 $3,000 $3,000 $3,000
Insurance $1,000 $1,000 $1,000 $1,000 $1,000 $1,000 $1,000 $1,000 $1,000 $1,000 $1,000 $1,000
Office Equipment $12,000 $0 $0 $3,000 $0 $6,000 $9,000 $0 $0 $0 $0 $0
Office Supplies $500 $500 $500 $500 $500 $500 $500 $500 $500 $500 $500 $500
Rent $5,000 $5,000 $5,000 $5,000 $5,000 $5,000 $5,000 $5,000 $5,000 $5,000 $5,000 $5,000
Payroll Taxes 30% $8,778 $8,778 $8,778 $8,778 $10,412 $12,240 $16,087 $16,087 $16,087 $16,087 $16,087 $16,087
Other General and Administrative Expenses $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------
Total General and Administrative Expenses $44,469 $32,469 $32,469 $35,469 $34,103 $48,023 $54,870 $45,870 $45,870 $45,870 $45,870 $45,870
General and Administrative % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Expenses:
Other Payroll $0 $0 $0 $0 $0 $0 $3,795 $3,795 $3,795 $3,795 $3,795 $3,795
Contract/Consultants $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------
Total Other Expenses $0 $0 $0 $0 $0 $0 $3,795 $3,795 $3,795 $3,795 $3,795 $3,795
Other % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------
Total Operating Expenses $52,329 $40,329 $40,329 $91,254 $41,963 $55,883 $126,450 $57,525 $57,525 $105,450 $82,525 $82,525
Profit Before Interest and Taxes ($103,988) ($48,238) ($48,238) ($142,914) ($55,319) ($69,239) ($192,586) ($79,911) ($79,911) ($171,586) ($104,911) ($104,911)
Interest Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Taxes Incurred $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Profit ($94,588) ($39,676) ($41,525) ($137,099) ($50,657) ($67,284) ($191,892) ($67,006) ($70,435) ($163,614) ($98,696) ($101,892)
Net Profit/Sales 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Include Negative Taxes

Page 4
 Appendix

Appendix Table: Cash Flow

Pro Forma Cash Flow Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun

Cash Received
Cash from Operations:
Cash Sales $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Cash from Receivables $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Subtotal Cash from Operations $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0

Additional Cash Received

Non Operating (Other) Income $4,700 $4,281 $3,356 $2,907 $2,331 $978 $347 $6,453 $4,738 $3,986 $3,108 $1,510
Sales Tax, VAT, HST/GST Received 0.00% $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
New Current Borrowing $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
New Other Liabilities (interest-free) $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
New Long-term Liabilities $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Sales of Other Current Assets $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Sales of Long-term Assets $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
New Investment Received $0 $0 $0 $0 $0 $0 $710,000 $0 $0 $0 $0 $0
Subtotal Cash Received $4,700 $4,281 $3,356 $2,907 $2,331 $978 $710,347 $6,453 $4,738 $3,986 $3,108 $1,510

Expenditures Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun
Expenditures from Operations:
Cash Spending $6,595 $1,020 $1,020 $10,488 $1,020 $1,620 $12,288 $1,020 $1,020 $10,188 $3,520 $3,520
Payment of Accounts Payable $40,017 $95,721 $47,218 $50,060 $136,666 $62,399 $87,491 $176,919 $78,891 $81,641 $159,399 $101,391
Subtotal Spent on Operations $46,612 $96,741 $48,238 $60,547 $137,686 $64,019 $99,779 $177,939 $79,911 $91,829 $162,919 $104,911

Additional Cash Spent

Non Operating (Other) Expense ($4,700) ($4,281) ($3,356) ($2,907) ($2,331) ($978) ($347) ($6,453) ($4,738) ($3,986) ($3,108) ($1,510)
Sales Tax, VAT, HST/GST Paid Out $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Principal Repayment of Current Borrowing $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Other Liabilities Principal Repayment $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Long-term Liabilities Principal Repayment $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Purchase Other Current Assets $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Purchase Long-term Assets $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Dividends $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Subtotal Cash Spent $41,912 $92,460 $44,882 $57,640 $135,355 $63,041 $99,432 $171,486 $75,173 $87,843 $159,811 $103,402

Net Cash Flow ($37,212) ($88,179) ($41,525) ($54,732) ($133,024) ($62,064) $610,915 ($165,033) ($70,435) ($83,857) ($156,703) ($101,892)
Cash Balance $432,789 $344,610 $303,084 $248,352 $115,328 $53,264 $664,179 $499,147 $428,711 $344,855 $188,152 $86,260

Page 5
 Appendix

Appendix Table: Balance Sheet

Pro Forma Balance Sheet

Assets
Current Assets Starting Balances Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun
Cash $470,000 $432,789 $344,610 $303,084 $248,352 $115,328 $53,264 $664,179 $499,147 $428,711 $344,855 $188,152 $86,260
Accounts Receivable $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Inventory $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Other Current Assets $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Total Current Assets $470,000 $432,789 $344,610 $303,084 $248,352 $115,328 $53,264 $664,179 $499,147 $428,711 $344,855 $188,152 $86,260
Long-term Assets
Long-term Assets $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Accumulated Depreciation $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Total Long-term Assets $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Total Assets $470,000 $432,789 $344,610 $303,084 $248,352 $115,328 $53,264 $664,179 $499,147 $428,711 $344,855 $188,152 $86,260

Liabilities and Capital

Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun
Accounts Payable $0 $57,377 $8,874 $8,874 $91,241 $8,874 $14,094 $106,901 $8,874 $8,874 $88,631 $30,624 $30,624
Current Borrowing $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Other Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Subtotal Current Liabilities $0 $57,377 $8,874 $8,874 $91,241 $8,874 $14,094 $106,901 $8,874 $8,874 $88,631 $30,624 $30,624

Long-term Liabilities $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $0 $57,377 $8,874 $8,874 $91,241 $8,874 $14,094 $106,901 $8,874 $8,874 $88,631 $30,624 $30,624

Paid-in Capital $472,713 $472,713 $472,713 $472,713 $472,713 $472,713 $472,713 $1,182,713 $1,182,713 $1,182,713 $1,182,713 $1,182,713 $1,182,713
Retained Earnings ($2,713) ($2,713) ($2,713) ($2,713) ($2,713) ($2,713) ($2,713) ($2,713) ($2,713) ($2,713) ($2,713) ($2,713) ($2,713)
Earnings $0 ($94,588) ($134,264) ($175,790) ($312,889) ($363,546) ($430,830) ($622,722) ($689,727) ($760,163) ($923,777) ($1,022,472) ($1,124,364)
Total Capital $470,000 $375,412 $335,736 $294,210 $157,111 $106,454 $39,170 $557,278 $490,273 $419,837 $256,223 $157,528 $55,636
Total Liabilities and Capital $470,000 $432,789 $344,610 $303,084 $248,352 $115,328 $53,264 $664,179 $499,147 $428,711 $344,855 $188,152 $86,260
Net Worth $470,000 $375,412 $335,736 $294,210 $157,111 $106,454 $39,170 $557,278 $490,273 $419,837 $256,223 $157,528 $55,636

Page 6